Stay updated on Ivosidenib+Venetoclax±Azacitidine in IDH1 Mutated Blood Cancers Clinical Trial

Sign up to get notified when there's something new on the Ivosidenib+Venetoclax±Azacitidine in IDH1 Mutated Blood Cancers Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ivosidenib+Venetoclax±Azacitidine in IDH1 Mutated Blood Cancers Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the context of Medical and healthcare-related publications and documentation.
    Difference
    0.3%
    Check dated 2024-06-06T14:39:54.000Z thumbnail image
  4. Check
    6 days ago
    No Change Detected
  5. Check
    7 days ago
    No Change Detected
  6. Check
    17 days ago
    Change Detected
    Summary
    The value on the webpage has been updated from 6 to 7, indicating a recent change in the number of medical and healthcare-related publications or documentation. This update may reflect new information or additional studies being added to the database.
    Difference
    0.3%
    Check dated 2024-05-22T21:32:45.000Z thumbnail image
  7. Check
    37 days ago
    Change Detected
    Summary
    The value -21 has recently changed to 05- on the webpage, indicating a shift in data related to Medical and healthcare publications and documentation.
    Difference
    0.3%
    Check dated 2024-05-03T07:48:14.000Z thumbnail image
  8. Check
    39 days ago
    Change Detected
    Difference
    3%
    Check dated 2024-04-30T22:26:19.000Z thumbnail image

Stay in the know with updates to Ivosidenib+Venetoclax±Azacitidine in IDH1 Mutated Blood Cancers Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ivosidenib+Venetoclax±Azacitidine in IDH1 Mutated Blood Cancers Clinical Trial page.